Laura Álvarez-Arroyo1, Francisco J Carrera-Hueso1, David El-Qutob2, Montserrat Robustillo-Villarino3, Ana M Girona-Sanz4, María T Pin-Godos5, Paula Sánchez-Monzó6, Rafael Martínez-Gonzálbez7, Sonia Cepeda-Madrigal8, Fernando Martínez-Martínez9. 1. Department of Pharmacy. Hospital Universitario de La Plana, Castellón, Spain. 2. Internal Medicine Department, Allergology Unit. Hospital Universitario de La Plana, Castellón, Spain. 3. Internal Medicine Department, Rheumatology Department. Hospital Universitario de La Plana, Castellón, Spain. 4. Internal Medicine Department, Digestive Medicine. Hospital Universitario de La Plana, Castellón, Spain. 5. Internal Medicine Department, Nephrology Department. Hospital Universitario de La Plana, Castellón, Spain. 6. Neurophysiology Unit. Hospital Universitario de La Plana, Castellón, Spain. 7. Informatics Unit. Hospital Universitario de La Plana, Castellón, Spain. 8. Internal Medicine Department, Pulmonology Department. Hospital Universitario de La Plana, Castellón, Spain. 9. Department of Pharmacy and Pharmaceutical Technology, Universidad de Granada, Granada, Spain.
Abstract
BACKGROUND: Several descriptive cohort studies of patients affected by COVID-19 have been published. OBJECTIVE: To describe the characteristics of patients with SARS-CoV-2 infection who were admitted to Hospital Universitario la Plana, Castellón, Spain. METHODS: Retrospective, observational cohort study that included 18-year-old or older patients who were consecutively admitted with SARS-CoV2 confirmed infection. Demographic characteristics, comorbidities, clinical symptoms, laboratory results and radiological tests are described. RESULTS: The study included 255 patients with a mean age of 70 years; 54.9 % were males. Most common comorbidities were high blood pressure (58 %), dyslipidemia (42.4 %), diabetes (25.5 %) and obesity (24.3 %). Median number of days from the onset of clinical symptoms prior to hospital admission was seven. Most common manifestations prior to admission were fever (74.5 %), dry cough (61.2 %), malaise (51.8 %) and dyspnea (51.0 %); 19 patients (7.4 %) were admitted to the intensive care unit, where mortality was 50 %; overall mortality was 16.9 %. CONCLUSIONS: Our cohort reflects similar characteristics to those of other European series. Mortality was lower than that in similar studies. Copyright:
BACKGROUND: Several descriptive cohort studies of patients affected by COVID-19 have been published. OBJECTIVE: To describe the characteristics of patients with SARS-CoV-2 infection who were admitted to Hospital Universitario la Plana, Castellón, Spain. METHODS: Retrospective, observational cohort study that included 18-year-old or older patients who were consecutively admitted with SARS-CoV2 confirmed infection. Demographic characteristics, comorbidities, clinical symptoms, laboratory results and radiological tests are described. RESULTS: The study included 255 patients with a mean age of 70 years; 54.9 % were males. Most common comorbidities were high blood pressure (58 %), dyslipidemia (42.4 %), diabetes (25.5 %) and obesity (24.3 %). Median number of days from the onset of clinical symptoms prior to hospital admission was seven. Most common manifestations prior to admission were fever (74.5 %), dry cough (61.2 %), malaise (51.8 %) and dyspnea (51.0 %); 19 patients (7.4 %) were admitted to the intensive care unit, where mortality was 50 %; overall mortality was 16.9 %. CONCLUSIONS: Our cohort reflects similar characteristics to those of other European series. Mortality was lower than that in similar studies. Copyright: